Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel DiseaseSare Verstockt, Séverine Vermeire, Bram Verstockt et al.|Inflammatory Bowel Diseases|2021Cited by 84
Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel DiseasesBram Verstockt, Marc Ferrante, Sare Verstockt et al.|Clinical Gastroenterology and Hepatology|2019Cited by 77
Outcome of biological therapies in chronic antibiotic‐refractory pouchitis: A retrospective single‐centre experienceBram Verstockt, Marc Ferrante, C Claeys et al.|United European Gastroenterology Journal|2019Cited by 59
Gene and Mirna Regulatory Networks During Different Stages of Crohn’s DiseaseSare Verstockt, Isabelle Cleynen, Maaike Vancamelbeke et al.|Journal of Crohn s and Colitis|2019Cited by 49
Intercellular interaction between FAP+ fibroblasts and CD150+ inflammatory monocytes mediates fibrostenosis in Crohn’s diseaseBo-Jun Ke, Gianluca Matteoli, Saeed Abdurahiman et al.|Journal of Clinical Investigation|2024Cited by 48